Viewing Study NCT01138657


Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2025-12-28 @ 9:41 PM
Study NCT ID: NCT01138657
Status: COMPLETED
Last Update Posted: 2021-07-07
First Post: 2010-05-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Adalimumab in Patients With Active Uveitis
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-08
Start Date Type: None
Primary Completion Date: 2014-07
Primary Completion Date Type: ACTUAL
Completion Date: 2014-08
Completion Date Type: ACTUAL
First Submit Date: 2010-05-14
First Submit QC Date: None
Study First Post Date: 2010-06-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-07-11
Results First Submit QC Date: None
Results First Post Date: 2016-08-22
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-08-03
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-07-02
Last Update Post Date: 2021-07-07
Last Update Post Date Type: ACTUAL